None
Quote | Palatin Technologies Inc. (NYSE:PTN)
Last: | $1.7899 |
---|---|
Change Percent: | 4.06% |
Open: | $1.72 |
Close: | $1.72 |
High: | $1.8401 |
Low: | $1.7 |
Volume: | 108,054 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Palatin Technologies Inc. (NYSE:PTN)
2024-04-08 10:00:33 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Top ...
2024-04-08 09:49:02 ET More on Palatin Tech Palatin Technologies, Inc. 2024 Q1 - Results - Earnings Call Presentation Palatin Technologies, Inc. (PTN) Q2 2024 Earnings Call Transcript Palatin stock plunges 40% on mixed Phase 3 data for dry eye drug Palatin Te...
Message Board Posts | Palatin Technologies Inc. (NYSE:PTN)
Subject | By | Source | When |
---|---|---|---|
HW says worth 75$ let start with 20$ | zeusgodmd | investorshub | 04/28/2023 5:09:07 PM |
Nice buys by me today longer term pay | zeusgodmd | investorshub | 04/28/2023 4:36:22 PM |
Amen brother. :) | chantillylive | investorshub | 04/24/2023 1:15:34 PM |
$Article on bio pharm companies cheap and getting | zeusgodmd | investorshub | 04/21/2023 11:49:22 AM |
Decent move on preliminary quarterly results for Vyleesi. | mike1986 | investorshub | 04/19/2023 6:11:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Palatin Technologies Inc. Company Name:
PTN Stock Symbol:
NYSE Market:
Palatin Technologies Inc. Website:
The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the c...
On Monday, Palatin Technologies Inc. (NYSE:PTN) announced the presentation of topline results for its Phase 3 PL9643 MELODY-1 trial, whic...
2024-04-08 08:01:14 ET DENVER, Colo., Apr 08, 2024 ( 247marketnews.com )- Palatin Technologies, Inc. (NYSE: PTN ) presented positive Phase 3 PL9643 MELODY-1 clinical trial results for the treatment of dry eye disease (DED) at the American Society of Cataract and Refractive Surgery (...